Therapy for adolescent and adult acute lymphoblastic leukemia: randomization of induction and consolidation therapies (preliminary results of EORTC Study 58791).
Stryckmans
P
P
Marie
J P
JP
Suciu
S
S
Solbu
G
G
Debusscher
L
L
Bury
J
J
Peetermans
M
M
Andrien
J M
JM
Fière
D
D
Cauchie
C
C
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005060:Europe; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D011897:Random Allocation; D012074:Remission Induction; D013866:Thioguanine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D003561:Cytarabine; D014750:Vincristine; D004317:Doxorubicin; D013866:Thioguanine; D011241:Prednisone; D008727:Methotrexate